An X-chromosomal association study identifies a susceptibility locus at Xq22.1 for hepatitis B virus-related hepatocellular carcinoma

Clinics and Research in Hepatology and Gastroenterology

Volumn 37, Issue 6, 2013, Pages 586-595

  Jiang, Jia Hao ^a,c   Gao, Qiang ^a,c   Shen, Xi Zhong ^a   Yu, Yao ^a,c   Gu, Fang Ming ^a,c   Yan, Jun ^a,c   Pan, Jin Feng ^a,c   Jin, Fei ^a   Fan, Jia ^a,b   Zhou, Jian ^a,b   Huang, Xiao Wu ^a,b  

^a FUDAN UNIVERSITY   (China)

^b Shanghai Key Laboratory of Organ Transplantation   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BEX1 PROTEIN; HEPATITIS B SURFACE ANTIGEN; NXF3 PROTEIN; ONCOPROTEIN; RAB40AL PROTEIN; UNCLASSIFIED DRUG;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANCER RISK; CHINESE; CONTROLLED STUDY; FAMILY HISTORY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; VIRUS CARRIER; X CHROMOSOME; X CHROMOSOME Q22.1; X CHROMOSOME RECESSIVE INHERITANCE;

ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CHINA; CHROMOSOMES, HUMAN, X; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HEPATITIS B, CHRONIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NUCLEOCYTOPLASMIC TRANSPORT PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA-BINDING PROTEINS;

EID: 84888433791     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2013.09.002     Document Type: Article

References (46)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
2. Xing J., Myers R.E., He X., et al. GWAS-identified colorectal cancer susceptibility locus associates with disease prognosis. Eur J Cancer 2011, 47:1699-1707.
3. Turnbull C. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet 2010, 42:504-507.
4. Amos C.I. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 2008, 40:616-623.
5. Totoki Y., Tatsuno K., Yamamoto S., et al. High-resolution characterization of a hepatocellular carcinoma genome. Nat Genet 2011, 43:464-469.
6. Kumar V., Kato N., Urabe Y., et al. Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma. Nat Genet 2011, 43:455-458.
7. Wu M.H., Ma W.L., Hsu C.L., et al. Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription. Sci Transl Med 2010, 2:32-35.
8. Yu M.W., Chang H.C., Chang S.C., et al. Role of reproductive factors in hepatocellular carcinoma: Impact on hepatitis B- and C-related risk. Hepatology 2003, 38:1393-1400.
9. Dobyns W.B., Filauro A., Tomson B.N., et al. Inheritance of most X-linked traits is not dominant or recessive, just X-linked. Am J Med Genet 2004, 129:136-143.
10. El-Serag H.B., Rudolph K.L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132:2557-2576.
11. Chen J.G., Zhang S.W. Liver cancer epidemic in China: past; present and future. Semin Cancer Biol 2010, 21:59-69.
12. Carlson C.S., Eberle M.A., Rieder M.J., Yi Q., Kruglyak L., Nickerson D.A. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Med Genet 2004, 74:106-120.
13. Buetow K.H., Edmonson M., MacDonald R., et al. High-throughput development and characterization of a genome wide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proc Natl Acad Sci U S A 2001, 98:581-584.
14. Erdfelder E., Faul F., Buchner A. GPOWER: a general power analysis program. Behav Res Methods 1996, 28:1-11.
15. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
16. Akaike H. Citation classic-a new look at the statistical-model identification 1981, 22. Current Contents/Engineering Technology & Applied Sciences.
17. Lewontin R.C. On measures of gametic disequilibrium. Genetics 1988, 120:849-852.
18. Altshuler D., Gabriel S.B., Schaffner S.F., et al. The structure of haplotype blocks in the human genome. Science 2002, 296:2225-2229.
19. Stephens M., Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Med Genet 2003, 73:1162-1169.
20. Johnson G.C., Esposito L., Barratt B.J., et al. Haplotype tagging for the identification of common disease genes. Nat Genet 2001, 29:233-237.
21. Liu Y., Zhang H., Zhou K., et al. Tagging SNPs in non-homologous end-joining pathway genes and risk of glioma. Carcinogenesis 2007, 28:1906-1913.
22. Cirulli E.T., Goldstein D.B. Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat Rev Genet 2010, 11:415-425.
23. Zhang H., Zhai Y., Hu Z., et al. Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers. Nat Genet 2010, 42:755-758.
24. Nahon P., Zucman-Rossi J. Single nucleotide polymorphisms and risk of hepatocellular carcinoma in cirrhosis. J Hepatol 2012, 57(3):663-674.
25. Wu L., Xu X., Shen J., et al. MDR1 gene polymorphisms and risk of recurrence in patients with hepatocellular carcinoma after liver transplantation. J Surg Oncol 2007, 96:62-68.
26. Casper M., Grunhage F., Lammert F. Cancer risk in chronic hepatitis B: do genome-wide association studies hit the mark?. Hepatology 2011, 53:1390-1392.
27. Li S., Qian J., Yang Y., et al. GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers. PLoS Genet 2012, 8:e1002791.
28. Chan K.Y., Wong C.M., Kwan J.S., et al. Genome-wide association study of hepatocellular carcinoma in Southern Chinese patients with chronic hepatitis B virus infection. PLoS One 2011, 6:e28798.
29. Little J., Higgins J.P., Ioannidis J.P., et al. STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Med 2009, 6:e22.
30. Ross M.T., Grafham D.V., Coffey A.J., et al. The DNA sequence of the human X chromosome. Nature 2005, 434:325-337.
31. Spatz A. Chromosome genetics X and human cancer. Nat Rev Cancer 2004, 4:617-629.
32. Fukuyama T., Hanagiri T., Takenoyama M., et al. Identification of a new cancer/germline gene, KK-LC-1, encoding an antigen recognized by autologous CTL induced on human lung adenocarcinoma. Cancer Res 2006, 66:4922-4928.
33. Ikeda K., Iyama K-i, Ishikawa N., et al. Loss of expression of type iv collagen α5 and α6 chains in colorectal cancer associated with the hypermethylation of their promoter region. Am J Pathol 2006, 168:856-865.
34. Niranjan V., Seenivasagam R., Sivakumar G. A systematic bioinformatics approach for selection of target and screening of ligand for malignant tumours suppressing APG4A gene on Xq22.1. Int J Comput Biol Drug Design 2010, 3:271-286.
35. Yang J., Bogerd H.P., Wang P.J., Page D.C., Cullen B.R. Two closely related human nuclear export factors utilize entirely distinct export pathways. Mol Cell 2001, 8:397-406.
36. Siddiqui N., Borden K.L.B. mRNA export and cancer. Wiley Interdiscip Rev Cancer 2011, 3:13-25.
37. van der Watt P.J., Leaner V.D. The nuclear exporter, Crm1, is regulated by NFY and Sp1 in cancer cells and repressed by p53 in response to DNA damage. Biochim Biophys Acta 2011, 1809:316-326.
38. Schutz S.V., Cronauer M.V., Rinnab L. Inhibition of glycogen synthase kinase-3beta promotes nuclear export of the androgen receptor through a CRM1-dependent mechanism in prostate cancer cell lines. J Cell Biochem 2010, 109:1192-1200.
39. van der Watt P.J., Maske C.P., Hendricks D.T., et al. The Karyopherin proteins, Crm1 and Karyopherin beta1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation. Int J Cancer 2009, 124:1829-1840.
40. Huang W.Y., Yue L., Qiu W.S., Wang L.W., Zhou X.H., Sun Y.J. Prognostic value of CRM1 in pancreas cancer. Clin Invest Med 2009, 32:E315.
41. Pascale R.M., Simile M.M., Calvisi D.F., et al. Role of HSP90, CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer. Hepatology 2005, 42:1310-1319.
42. Pihur V., Datta S. Finding common genes in multiple cancer types through meta-analysis of microarray experiments: a rank aggregation approach. Genomics 2008, 92:400-403.
43. Hofmann O., Caballero O.L., Stevenson B.J., et al. Genome-wide analysis of cancer/testis gene expression. Proc Natl Acad Sci U S A 2008, 105:20422-20427.
44. Foltz G., Ryu G.Y., Yoon J.G., et al. Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma. Cancer Res 2006, 66:6665-6674.
45. Quentmeier H., Tonelli R., Geffers R., Pession A., Uphoff C.C., Drexler H.G. Expression of BEX1 in acute myeloid leukemia with MLL rearrangements. Leukemia 2005, 19:1488-1489.
46. Saito-Ohara F., Fukuda Y., Ito M., et al. The Xq22 inversion breakpoint interrupted a novel Ras-like GTPase gene in a patient with Duchenne muscular dystrophy and profound mental retardation. Am J Hum Genet 2002, 71:637-645.